TB Notes Newsletter

No. 4, 2011

NEW CDC PUBLICATIONS

Barnes RFW, Moore ML, Garfein RS, Brodine S, Strathdee SA, and Rodwell TC. Trends in mortality of tuberculosis patients in the United States: the long-term perspective. Annals of Epidemiology 2011 Oct; 21 (10): 791-795.

Bloss E, Newbill K, Peto H, Rice MJ, Ainsworth G, Travnicek R, Holcombe M, Haddad MB, and Oeltmann JE. Challenges and opportunities in a tuberculosis outbreak investigation in southern Mississippi, 2005 – 2007. Southern Med J. 2011 Nov; 104(11): 731-5.

Castro KG, Cohn DL, Burman WJ, Reves RR, Iseman MD. John A. Sbarbaro, 1936–2011. [Obituary.] IJTLD 2011 Nov; 15 (11): 1562.

Cavanaugh J, Genga K, Marigu I, Laserson K, Ackers M, Cain K. Tuberculosis among children in Kenya: epidemiology and impact of HIV in two provinces. J Trop Pediatr 2011 Dec 5. [Epub ahead of print.]

Chaisson LH, Kass NE, Chengeta B, Mathebula U, Samandari T. Repeated assessments of informed consent comprehension among HIV-infected participants of a three-year clinical trial in Botswana. PLoS ONE 2011; 6(10): e22696. doi:10.1371/journal.pone.0022696.

Davidson CS, Green CF, Gibbs SG, Panlilio AL, Jensen PA, Jin Y, Scarpino PV. Feasibility of selected prophylactic barriers in arrestance of airborne bacterial vegetative cells and endospores. Am J Infect Control 2011; 39: 581-6.

Davidson C, Green CF, Panlilio AL, Jensen PA, Stover BH, Roselle G, Gibbs SG, and Scarpino PV. Method for evaluating the relative efficiency of selected N95 respirators and surgical masks to prevent the inhalation of airborne vegetative cells by healthcare personnel. Indoor and Built Environment 2011 Apr; 20 (2): 265-277.

Dharmadhikari AS, Basaraba RJ, Van Der Walt ML, Weyer K, Mphahlele M, Venter K, Jensen PA, First MW, Parsons S, McMurray DN, Orme IM, and Nardell EA. Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis. Tuberculosis 2011 Jul; 91 (4): 329-338.

Factor SH, Sackoff JE, Raj-Singh S, Wu Y, Monserrate J, Munsiff S, and Vlahov D. Street-outreach improves detection but not referral for drug users with latent tuberculosis, New York City. Journal: Substance Use & Misuse 2011; 46 (14): 1711-1715.

Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I,  Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MID, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski JP. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects. Int J Tuberc Lung Dis 2011; 15(10):1315–1322.

Ghosh S, Moonan PK, Cowan L, Grant J, Kammerer S, Navin T. Tuberculosis Genotyping Information Management System: Enhancing tuberculosis surveillance in the United States. Infection, Genetics, and Evolution 2011; doi: 10.1016/ j.meegid.2011.10.013.

Grinsdale JA, Ho CS, Banouvong H, Kawamura LM. Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities. Int J Tuberc Lung Dis 2011 Dec; 15(12):1614–1619.

He GX, Wang HY, Borgdorff MW, van Soolingen D, van der Werf MJ, Liu ZM, Li XZ, Guo H, Zhao YL, Varma JK, Tostado CP, van den Hof S. Multidrug-resistant tuberculosis, People’s Republic of China, 2007–2009. Emerg Infect Dis [serial on the Internet]. 2011 Oct.

Heilig CM, Chia D, El-Sadr WM, Hirsch-Moverman Y, Mac Kenzie WR, Saukkonen S, Villarino ME, and Padayatchi N. Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis. IRB: Ethics & Human Research 2011 July-August; 33 (4): 10-17.

Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, Zajdowicz MJ, Scarborough R, LoBue PA, Lardizabal AA, Daley CL8, Reves RR, Bernardo J, Campbell BH, Whitworth WC, Mazurek GH. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS ONE 2011; 6(11): e26545. doi:10.1371/journal.pone.0026545

Lee LM, Heilig CM, White A. Ethical justification for conducting public health surveillance without patient consent. Am J Public Health 2011 Nov 17; e1-e7. Published online ahead of print; doi: 10.2105/AJPH.2011.300297.

Lin H, Shin S, Blaya JA, Zhang Z, Cegielski P, Contreras C, Asencios L, Bonilla C, Bayona J, Paciorek CJ, and Cohen T. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiology and Infection 2011 Nov; 139 (11): 1784-1793.

Lowther SA, Miramontes R, Navara B, Sabuwala N, Brueshaber M, Solarz S, Haddad MB, Sodt D, Lynfield R. Outbreak of tuberculosis among Guatemalan immigrants in rural Minnesota, 2008. Public Health Rep 2011 Sept-Oct; 126:726-732.

Macintyre K and Bloss E. Alcohol brewing and the African tuberculosis epidemic. Med Anthropol 2011 Mar; 30 (2): 126-35.

Magee M, Bloss E, Shin S, Contreras C, Huaman HA, Ticona JC, Bayona J, Bonilla JC, Yagui M, Jave O, and Cegielski P. Factors associated with drug-resistant tuberculosis (DRTB) among patients with tuberculosis (TB) and diabetes mellitus (DM) in Peru. American Journal of Epidemiology 2011 Jun 1; 173: S182-S182.

Napier RJ, Rafi W, Cheruvu M, Powell KR, Zaunbrecher MA, Bornmann W, Salgame P, Shinnick TM, Kalman D. Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host & Microbe 2011 Nov 17; 10: 475-485.

Pevzner ES, Vandebriel G, Lowrance DW, Gasana M, and Finlay A. Evaluation of the rapid scale-up of collaborative TB/HIV activities in TB facilities in Rwanda, 2005-2009. BMC Public Health 2011 July; 11: 550.

Powell K, Han D, Hung NV, Vu T, Sy DN, Trinh TT, Le TC, Do K, Oeltmann JE,  Whitehead S. Prevalence and risk factors for tuberculosis infection among personnel in two hospitals in Viet Nam. Int J Tuberc Lung Dis 2011; 15(12):1643–1648.

Powell RD III, Whitworth WC, Bernardo J, Moonan PK, Mazurek GH. Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests. PLoS ONE 2011; 6(6): e20061. doi:10.1371/journal.pone.0020061

Ricks PM, Cain KP, Oeltmann JE , Kammerer JS, Moonan PK. Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005–2009. PLoS ONE 2011; 6(11): e27405. doi:10.1371/journal.pone.0027405

Sable SB, Cheruvu M, Nandakumar S, Sharma S, Bandyopadhyay K, Kellar KL, Posey JE, Plikaytis BB, Amara RR, and Shinnick TM. Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. PLoS ONE 2011; 6(7): e22718; doi:10.1371/ journal.pone.0022718.

Saito H, Iwamoto T, Ohkusu K, Otsuka Y, Akiyama Y, Sato S, Taguchi O, Sueyasu Y, Kawabe Y, Fujimoto H, Ezaki  T, and Butler R.  Mycobacterium shinjukuense sp. Nov., a slowly growing , non-chromogenic species isolated from human clinical specimens.  IJSEM. V61; 1927-1932,2011. DOI 10.1099/ijs.0.025478-0

Samandari T, Moeti T, Talbot E, Agizew T, Nyirenda S. Author’s reply. [Correspondence.] The Lancet 2011 Oct 1; 378; 1216.

Simmon, Keith E., Barbara A. Brown-Elliott, Perry G. Ridge, Jacob D. Durtschi, Linda B. Mann, E. Susan Slechta, Arnold G. Steigerwalt, Benjamin D. Moser, Anne M. Whitney, June M. Brown, Karl V. Voelkerding, Karin L. McGowan, Anne F. Reilly, Thomas J. Kirn, W. Ray Butler, Paul H. Edelstein, Richard J. Wallace, and Cathy A Petti.  Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, northeastern USA.  EID. V17, #9, Sep. 2011.  ISSN 1080-6059

Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski  JP. Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis. [Short communication.] Int J Tuberc Lung Dis e-publication ahead of print 2 December 2011; available at http://dx.doi.org/10.5588/ijtld.11.0445.

Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, Amara RR, Lafuse WP, Shinnick TM, Sable SB. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis 2011 July; 91 (4): 314-321.

Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Dukes Hamilton C, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR, Jr., Chaisson RE, for the TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365:2155-66.

Thamthitiwat S, Marin N, Baggett HC, Peruski LF, Kiatkulwiwat W, Panumatrasmee V, Varma JK, Nateniyom S, Akarasewi P, Maloney SA. Mycobacterium bovis (bacille Calmette-Guerin) bacteremia in immunocompetent neonates following vaccination. [Short communication.] Vaccine 2011; 29: 1727-1730.

Weisenberg SA, Gibson AL, Huard RC, Kurepina N, Bang H, Lazzarini LCO, Chiu Y, Li J, Ahuja S, Driscoll J, Kreiswirth BN. Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RDRio Mycobacterium tuberculosis sublineage. Infection, Genetics, and Evolution 2011; doi: 10.1016/
j.meegid.2011.07.018.

Winston CA, Navin TR, Becerra JE, Chen MP, Armstrong LR, Jeffries C, Woodruff RSY, Wing J, Starks AM, Hales CM, Kammerer JS, Mac Kenzie WR, Mitruka K, Miner MC, Price S, Scavotto J, Cronin AM, Griffin P, LoBue PA and Castro KG. Unexpected decline in tuberculosis cases coincident with economic recession – United States, 2009. BMC Public Health 2011; 11:846; doi:10.1186/1471-2458-11-846.

Top of Page